Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Industrifonden on the investment in Nanofactory Instruments
Mandate

Vinge advises Industrifonden on the investment in Nanofactory Instruments

November 27, 2007

Industrifonden will invest MSEK 9 in Nanofactory Instruments, a Gothenburg company that develops scientific instruments within nanotechnology. These instruments will give scientists a better understanding of how different materials work at an atomic level, which is of great importance to many industries. The total investment of MSEK 13 will be used to further develop Nanofactory’s product programme and to strengthen the company’s sales, installation and user support functions. 

Industrifonden is represented by partner Johan Winnerblad with assistance from Johan Larsson.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026